Influence of Diabetes and Cardiovascular Disease on the Long-Term Incidence of Cataract: The Blue Mountains Eye Study

REFERENCES

• Hennis A, Wu S Y, Li X, Nemesure B, Leske M C. Lens opacities and mortality: The Barbados Eye Studies. Ophthalmology 2001; 108: 498–504
   PubMed Web of Science ®Google Scholar
• Goodrich M E, Cumming R G, Mitchell P, Koutts J, Burnett L. Plasma fibrinogen and other cardiovascular disease risk factors and cataract. Ophthalmic Epidemiol 1999; 6: 279–290
   PubMedGoogle Scholar
• Leske M C, Wu S Y, Hennis A, Connell A M, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology 1999; 106: 35–41
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Jensen S C, Linton K L. Hypertension and lens opacities from the Beaver Dam Eye Study. Am J Ophthalmol 1995; 119: 640–646
   PubMedGoogle Scholar
• Burgess C A, Sowers M. Systemic hypertension and senile cataracts: An epidemiologic study. Optom Vis Sci 1992; 69: 320–324
   Google Scholar
• Hiller R, Sperduto R D, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol 1986; 124: 916–925
   PubMed Web of Science ®Google Scholar
• Kahn H A, Leibowitz H M, Ganley J P, Kini M M, Colton T, Nickerson R S, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 1977; 106: 33–41
   PubMed Web of Science ®Google Scholar
• Arnarsson A, Jonasson F, Sasaki H, Ono M, Jonsson V, Kojima M, et al. Risk factors for nuclear lens opacification: The Reykjavik Eye Study. Dev Ophthalmol 2002; 35: 12–20
   PubMedGoogle Scholar
• The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol 1991; 133: 541–553
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Lee K E. Cardiovascular disease, selected cardiovascular disease risk factors, and age-related cataracts: The Beaver Dam Eye Study. Am J Ophthalmol 1997; 123: 338–346
   PubMed Web of Science ®Google Scholar
• Delcourt C, Cristol J P, Tessier F, Leger C L, Michel F, Papoz L. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: The POLA study. Pathologies Oculaires Liees a l'Age. Am J Epidemiol 2000; 151: 497–504
   PubMed Web of Science ®Google Scholar
• Donnelly C A, Seth J, Clayton R M, Phillips C I, Cuthbert J. Some plasma constituents correlate with human cataract location and nuclear colour. Ophthalmic Res 1997; 29: 207–217
   Google Scholar
• Mukesh B N, Le A, Dimitrov P N, Ahmed S, Taylor H R, McCarty C A. Development of cataract and associated risk factors: The Visual Impairment Project. Arch Ophthalmol 2006; 124: 79–85
   PubMedGoogle Scholar
• Schaumberg D A, Glynn R J, Christen W G, Ajani U A, Sturmer T, Hennekens C H. A prospective study of blood pressure and risk of cataract in men. Ann Epidemiol 2001; 11: 104–11
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Moss S E. Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995; 119: 295–300
   PubMed Web of Science ®Google Scholar
• Hiller R, Podgor M J, Sperduto R D, Nowroozi L, Wilson P W, D'Agostino R B, et al. A longitudinal study of body mass index and lens opacities. The Framingham Studies. Ophthalmology 1998; 105: 1244–1250
   PubMed Web of Science ®Google Scholar
• Schaumberg D A, Glynn R J, Christen W G, Hankinson S E, Hennekens C H. Relations of body fat distribution and height with cataract in men. Am J Clin Nutr 2000; 72: 1495–1502
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Lee K E. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: The Beaver Dam Eye Study. Am J Ophthalmol 1998; 126: 782–790
   PubMed Web of Science ®Google Scholar
• Rowe N, Mitchell P, Cumming R G, Wang J J. Diabetes, fasting blood glucose and age-related cataract: The Blue Mountains Eye Study. Ophthal Epidemiol 2000; 7: 103–114
   PubMedGoogle Scholar
• Younan C, Mitchell P, Cumming R, Rochtchina E, Panchapakesan J, Tumuluri K. Cardiovascular disease, vascular risk factors and the incidence of cataract and cataract surgery: The Blue Mountains Eye Study. Ophthalmic Epidemiol 2003; 10: 227–240
   PubMed Web of Science ®Google Scholar
• Saxena S, Mitchell P, Rochtchina E. Five-year incidence of cataract in older persons with diabetes and pre-diabetes. Ophthalmic Epidemiol 2004; 11: 271–277
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, Wang J J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450–1460
   PubMed Web of Science ®Google Scholar
• Kanthan G L, Wang J J, Rochtchina E, Tan A G, Lee A, Chia E M, et al. Ten-year incidence of age-related cataract and cataract surgery in an older Australian population: The Blue Mountains Eye Study. Ophthalmology 2008; 115: 808–814
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Linton K L, Magli Y L, Neider M W. Assessment of cataracts from photographs in the Beaver Dam Eye Study. Ophthalmology 1990; 97: 1428–1433
   PubMed Web of Science ®Google Scholar
• Mitchell P, Cumming R G, Attebo K, Panchapakesan J. Prevalence of cataract in Australia: The Blue Mountains eye study. Ophthalmology 1997; 104: 581–588
   PubMed Web of Science ®Google Scholar
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983–1992
   PubMed Web of Science ®Google Scholar
• Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553
   PubMed Web of Science ®Google Scholar
• Klein B E, Klein R, Wang Q, Moss S E. Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 1995; 2: 49–55
   PubMedGoogle Scholar
• Janghorbani M B, Jones R B, Allison S P. Incidence of and risk factors for cataract among diabetes clinic attenders. Ophthalmic Epidemiol 2000; 7: 13–25
   PubMedGoogle Scholar
• Dobbs R E, Smith J P, Chen T, Knowles W, Hockwin O. Long-term follow-up of lens changes with Scheimpflug photography in diabetics. Ophthalmology 1987; 94: 881–890
   PubMed Web of Science ®Google Scholar
• Karasik A, Modan M, Halkin H, Treister G, Fuchs Z, Lusky A. Senile cataract and glucose intolerance: The Israel Study of Glucose Intolerance Obesity and Hypertension (The Israel GOH Study). Diabetes Care 1984; 7: 52–56
   PubMed Web of Science ®Google Scholar
• Di Benedetto A, Aragona P, Romano G, Romeo G, Di Cesare E, Spinella R, et al. Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients. J Diabetes Complications 1999; 13: 159–162
   PubMedGoogle Scholar
• Stitt A W. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol 2001; 85: 746–753
   PubMed Web of Science ®Google Scholar
• Lee A Y, Chung S K, Chung S S. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA 1995; 92: 2780–2784
   PubMed Web of Science ®Google Scholar
• Mota M C, Carvalho P, Ramalho J S, Cardoso E, Gaspar A M, Abreu G. Protein glycation and in vivo distribution of human lens fluorescence. Int Ophthalmol 1994; 18: 187–193
   Google Scholar
• Leske M C, Chylack L T, Jr., He Q, Wu S Y, Schoenfeld E, Friend J, et al. Risk factors for nuclear opalescence in a longitudinal study. LSC Group. Longitudinal Study of Cataract. Am J Epidemiol 1998; 147: 36–41
   PubMedGoogle Scholar
• Chen L K, Buchan A M, Hwang S J, Hinkle J. Cataract surgery after acute stroke: Maybe more than a coincidence. Stroke 2006; 37: 766–767
   Google Scholar
• Hu F B, Hankinson S E, Stampfer M J, Manson J E, Colditz G A, Speizer F E, et al. Prospective study of cataract extraction and risk of coronary heart disease in women. Am J Epidemiol 2001; 153: 875–881
   Google Scholar
• Schaumberg D A, Ridker P M, Glynn R J, Christen W G, Dana M R, Hennekens C H. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol 1999; 9: 166–171
   PubMed Web of Science ®Google Scholar
• Hutnik C M, Nichols B D. Cataracts in systemic diseases and syndromes. Curr Opin Ophthalmol 1999; 10: 22–28
   PubMedGoogle Scholar
• Danesh J, Lewington S, Thompson S G, Lowe G D, Collins R, Kostis J B, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 2005; 294: 1799–1809
   PubMed Web of Science ®Google Scholar
• Cheung N, Wong T Y. Obesity and eye diseases. Surv Ophthalmol 2007; 52: 180–195
   PubMed Web of Science ®Google Scholar
• Glynn R J, Christen W G, Manson J E, Bernheimer J, Hennekens C H. Body mass index. An independent predictor of cataract. Arch Ophthalmol 1995; 113: 1131–1137
   PubMed Web of Science ®Google Scholar
• Cumming R G, Mitchell P. Medications and cataract. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 1751–1758
   Web of Science ®Google Scholar
• Eckel R H, Grundy S M, Zimmet P Z. The metabolic syndrome. Lancet 2005; 365: 1415–1428
   PubMed Web of Science ®Google Scholar
• Panchapakesan J, Cumming R G, Mitchell P. Reproducibility of the Wisconsin cataract grading system in the Blue Mountains Eye Study. Ophthalmic Epidemiol 1997; 4: 119–126
   PubMedGoogle Scholar